Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Medikit Co Ltd (7749)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2,828.0 -72.0    -2.48%
01:59:55 - Closed. Currency in JPY ( Disclaimer )
  • Volume: 2,000
  • Bid/Ask: 2,828.0 / 2,858.0
  • Day's Range: 2,828.0 - 2,890.0
Type:  Equity
Market:  Japan
ISIN:  JP3921060004 
Medikit 2,828.0 -72.0 -2.48%

7749 Balance Sheet

 
Featured here, the Balance Sheet for Medikit Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 38383 38820 37807 38176
Cash and Short Term Investments 27462 28445 27443 27592
Cash - - - -
Cash & Equivalents 27462 28445 27443 27592
Short Term Investments - - - -
Total Receivables, Net 5870 5266 5376 5691
Accounts Receivables - Trade, Net 5870 5266 5376 5691
Total Inventory 3447 3430 3325 3281
Prepaid Expenses - - - -
Other Current Assets, Total 1604 1679 1663 1612
Total Assets 54191 54267 52749 53186
Property/Plant/Equipment, Total - Net 10926 10392 10362 10438
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 2392 2446 1894 1935
Intangibles, Net 1141 1146 1151 1157
Long Term Investments 1061 1075 1096 1077
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 1 1 1 1
Other Assets, Total -532 230 50 -396
Total Current Liabilities 5102 5396 4812 4673
Accounts Payable 3229 2582 2478 2545
Payable/Accrued - - - -
Accrued Expenses 206 415 215 413
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total 1667 2399 2119 1715
Total Liabilities 6328 6619 6036 5895
Total Long Term Debt - - - -
Long Term Debt - - - -
Capital Lease Obligations - - - -
Deferred Income Tax 333 333 332 330
Minority Interest - - - -
Other Liabilities, Total 893 890 892 892
Total Equity 47863 47648 46713 47291
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 1241 1241 1241 1241
Additional Paid-In Capital 10392 10392 10384 10384
Retained Earnings (Accumulated Deficit) 38888 38665 37908 38519
Treasury Stock - Common -3230 -3230 -3243 -3243
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 572 580 423 390
Total Liabilities & Shareholders' Equity 54191 54267 52749 53186
Total Common Shares Outstanding 16.8 16.8 16.79 16.79
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

7749 Comments

Write your thoughts about Medikit Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email